ORGANON SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Organon & Co.

A securities class action lawsuit has been filed against Organon & Co. (OGN) on behalf of investors who purchased securities between October 31, 2024, and April 30, 2025, alleging violations of federal securities laws related to the company's dividend payout. Specifically, the lawsuit claims Organon misled investors by assuring them of its commitment to its dividend strategy, only to drastically reduce the dividend from $0.28 to $0.02 in Q1 2025, causing the stock price to fall over 27% on the news. Investors have until July 22, 2025, to file lead plaintiff applications.

Analysis

Organon & Co. (NYSE: OGN) is currently embroiled in a securities class action lawsuit, alleging the company and its executives violated federal securities laws by failing to disclose material information to investors between October 31, 2024, and April 30, 2025. The central claim revolves around a significant shift in the company's dividend policy. Despite prior assurances that the regular quarterly dividend was a "number one priority" and commitment to its capital allocation strategy, Organon announced on March 10, 2025, a drastic reduction in its Q1 2025 dividend from $0.28 to $0.02 per share. This news triggered a sharp decline in Organon's stock price, which fell over 27% from a closing price of $12.93 per share on April 30, 2025, to $9.45 per share on May 1, 2025. The lawsuit, Hauser V. Organon & Co., et al., No. 25-cv-05322, is pending in the United States District Court for the District of New Jersey, and investors have until July 22, 2025, to file lead plaintiff applications. The associated sentiment for OGN is strongly negative (-0.9), reflecting the severe market reaction to the unexpected dividend cut and subsequent legal challenge, indicating a breach of investor trust and a material adverse change to the company's perceived financial stability and commitment to shareholder returns.

Key Decisions for Investors

• Investors who purchased Organon & Co. securities during the Class Period (October 31, 2024 - April 30, 2025) should be aware of the July 22, 2025 deadline to file for lead plaintiff status in the ongoing class action lawsuit and may wish to consult legal counsel.
• The drastic dividend cut and subsequent legal proceedings introduce significant uncertainty and headline risk for OGN, warranting a cautious approach and thorough due diligence before initiating or adding to positions.
• Current and prospective investors should closely monitor developments in the class action lawsuit and any further communications from Organon management regarding its capital allocation strategy and future dividend policy, as these will be critical to assessing the company's investment profile.